Topic

Articles

Jody Casey of Elligo Health Research gives insight into the issue of diversity in trials and what needs to be done to correct it.

COVID-19 Highlights Need for More Diversity in Trials

Practical suggestions for identifying what actionable insights have been impactful on clinical studies. 

How to Measure Your Patient-Centric Impact

The pandemic has thus far disproportionally impacted minority populations, and our ongoing failure to adequately represent all patients regardless of demographic background has never been more important to remedy than it is today, writes ACRP Workforce Innovation Officer Beth Harper. 

The Time is Now to Promote Clinical Trial Workforce Diversity

Beyond technology, awareness, and access—cultural competence is key.

Diversity in Clinical Trials: Path to Achieving Health Equity

Past decades have shown gender-based differences in clinical trial results are often overlooked when considering safety and effectiveness.  

Gender Bias in the Clinical Evaluation of Drugs

This article highlights how C2N Diagnostics and Firma Clinical Research teamed up to create a successful Alzheimer's diagnostic clinical trial while allowing participants to remain in their homes.

Key Points to Success in Decentralized Alzheimer’s Diagnostic Clinical Trial

How integrated data platforms can help find the best-suited patients for cancer studies and reduce the burden on care teams.

Busting Patient Recruitment Bottlenecks in Oncology Trials

Case study focused on quest for potential Parkinson’s biomarker highlights opportunities and challenges in site selection.

The Importance of Site Selection

Recruitment study tests the use of a ride-sharing service.

Overcoming Transportation Barriers to Trial Participation

Exploring the Institute for Neurodegenerative Disorders’ non-traditional approach to engaging community physicians.

Patient Participation